ArticleFrontiers in public health2026
Development and validation of an interpretable machine learning model for predicting ADHD comorbidity in children with allergic rhinitis: a SHAP-based analysis.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The co-occurrence of allergic rhinitis (AR) and attention-deficit/hyperactivity disorder (ADHD) presents significant clinical challenges in pediatrics, yet predictive tools capturing non-linear neuro-immune interactions are lacking. Methods: We developed an interpretable Extreme Gradient Boosting (XGBoost) model utilizing a hybrid feature selection pipeline on a cohort of 518 pediatric AR patients (255 with comorbid ADHD). Model performance was evaluated via an independent test set. Global and local interpretability was decoded using SHapley Additive exPlanations (SHAP). Results: A parsimonious subset of six predictors was identified. The XGBoost model achieved superior discriminative capacity (AUC = 0.878) compared to conventional linear baselines. SHAP topographical analysis revealed profound non-linear thresholds and uncovered a critical synergistic interaction: elevated ADHD risk was strongly correlated with patients presenting simultaneously severe allergic inflammation (Total IgE > 250 IU/mL) and nutritional deficiency (Vitamin D < 20 ng/mL). Furthermore, Decision Curve Analysis (DCA) demonstrated substantial net clinical benefit for triage application. Conclusion: We established a highly robust, interpretable machine learning algorithm capable of accurately stratifying ADHD risk among AR children. The identified neuro-immune synergistic phenotypes provide critical mechanistic insights and offer a practical decision-support tool for timely pediatric multidisciplinary interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.